Alphinity Investment Management Pty LTD Abb Vie Inc. Transaction History

Alphinity Investment Management Pty LTD

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 13, 2018	SELL	$89.78 - $106.23 $11.8 Million - $13.9 Million	-131,060 Closed	0 $0
Q1 2018 May 09, 2018	BUY	$92.01 - $123.21 $5.03 Million - $6.73 Million	54,652 Added 71.53%	131,060 $12.4 Million
Q4 2017 Feb 13, 2018	BUY	$89.56 - $98.21 $6.84 Million - $7.5 Million	76,408	76,408 $7.39 Million

3,650

1.24B

15.5M

11.5M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $305B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Alphinity Investment Management Pty LTD, based on Form 13F filings with the SEC.

Stay updated on Alphinity Investment Management Pty LTD with notifications on news.